Qube Research & Technologies (QRT)
LAB icon

Qube Research & Technologies (QRT)’s Standard BioTools LAB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Buy
4,820,463
+4,116,056
+584% +$3.89M ﹤0.01% 1753
2026
Q1 		$648K Buy
704,407
+487,258
+224% +$590K ﹤0.01% 2654
2025
Q4 		$278K Sell
217,149
-65,694
-23% -$88.3K ﹤0.01% 2971
2025
Q3 		$368K Sell
282,843
-158,258
-36% -$207K ﹤0.01% 2795
2025
Q2 		$529K Buy
441,101
+20,979
+5% +$23.3K ﹤0.01% 2672
2025
Q1 		$454K Sell
420,122
-71,063
-14% -$99.8K ﹤0.01% 2577
2024
Q4 		$860K Buy
491,185
+353,045
+256% +$658K ﹤0.01% 2243
2024
Q3 		$267K Sell
138,140
-1,090,992
-89% -$2.14M ﹤0.01% 2471
2024
Q2 		$2.18M Sell
1,229,132
-487,835
-28% -$1.19M ﹤0.01% 1579
2024
Q1 		$4.65M Buy
+1,716,967
New +$4.14M 0.01% 1276
2023
Q4 		– Sell
-19,085
Closed -$55.3K – 4559
2023
Q3 		$55.3K Buy
+19,085
New +$49.9K ﹤0.01% 2841
2023
Q2 		– Sell
-10,968
Closed -$21.4K – 2722
2023
Q1 		$21.4K Buy
+10,968
New +$21.7K ﹤0.01% 2303
2022
Q4 		– Sell
-61,366
Closed -$68K – 2765
2022
Q3 		$68K Sell
61,366
-6,192
-9% -$9.36K ﹤0.01% 2071
2022
Q2 		$108K Buy
+67,558
New +$167K ﹤0.01% 1920

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LAB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Standard BioTools (LAB) stake by 584% in Q2 2026, buying an estimated $3.89M and bringing the position to 4,820,463 shares worth $3.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Qube Research & Technologies (QRT) first reported a position in LAB in Q2 2022 and has held it in 14 quarters since. The position peaked at $4.65M in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 4,820,463 shares of Standard BioTools worth $3.97M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 4,116,056 Standard BioTools shares in Q2 2026, an estimated $3.89M.
  • Standard BioTools made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1753 holding.
  • Qube Research & Technologies (QRT) first reported a position in Standard BioTools in Q2 2022 and has held it in 14 quarters since.
  • Qube Research & Technologies (QRT)'s Standard BioTools position peaked at $4.65M in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.